Gradient Investments LLC Increases Stake in Lam Research Corporation $LRCX

Key Points

• Gradient Investments LLC increased its stake in Lam Research Corporation by 4.5%, owning a total of 244,452 shares valued at approximately $23.8 million after acquiring additional shares in the second quarter.
• Lam Research reported earnings per share of $1.33 for the last quarter, exceeding analysts' expectations and representing a 33.6% year-over-year revenue increase to $5.17 billion.
• The company has announced an increase in its quarterly dividend from $0.23 to $0.26 per share, which reflects an annualized yield of 0.9%.

Gradient Investments LLC lifted its stake in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 4.5% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 244,452 shares of the semiconductor company's stock after buying an additional 10,427 shares during the quarter. Gradient Investments LLC's holdings in Lam Research were worth $23,795,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently modified their holdings of LRCX. Meridian Wealth Management LLC grew its holdings in Lam Research by 1.4% in the first quarter. Meridian Wealth Management LLC now owns 9,732 shares of the semiconductor company's stock worth $707,000 after purchasing an additional 130 shares during the period. GW&K Investment Management LLC grew its holdings in Lam Research by 10.1% in the first quarter. GW&K Investment Management LLC now owns 1,534 shares of the semiconductor company's stock worth $112,000 after purchasing an additional 141 shares during the period. Dorsey & Whitney Trust CO LLC grew its holdings in Lam Research by 1.2% in the first quarter. Dorsey & Whitney Trust CO LLC now owns 12,498 shares of the semiconductor company's stock worth $909,000 after purchasing an additional 146 shares during the period. Fiduciary Financial Group LLC grew its holdings in Lam Research by 3.8% in the second quarter. Fiduciary Financial Group LLC now owns 4,073 shares of the semiconductor company's stock worth $394,000 after purchasing an additional 150 shares during the period. Finally, Citizens National Bank Trust Department grew its holdings in Lam Research by 34.0% in the first quarter. Citizens National Bank Trust Department now owns 603 shares of the semiconductor company's stock worth $44,000 after purchasing an additional 153 shares during the period. Hedge funds and other institutional investors own 84.61% of the company's stock.

Analyst Upgrades and Downgrades

LRCX has been the topic of a number of recent research reports. Summit Insights cut shares of Lam Research from a "buy" rating to a "hold" rating in a report on Thursday, July 31st. Cantor Fitzgerald upped their price objective on shares of Lam Research from $115.00 to $120.00 and gave the stock an "overweight" rating in a report on Thursday, August 21st. Mizuho upped their target price on shares of Lam Research from $120.00 to $130.00 and gave the stock an "outperform" rating in a research note on Friday. Oppenheimer increased their price target on shares of Lam Research from $110.00 to $120.00 and gave the company an "outperform" rating in a report on Thursday, July 31st. Finally, TD Cowen increased their price target on shares of Lam Research from $100.00 to $125.00 and gave the company a "buy" rating in a report on Thursday, July 31st. Twenty investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $107.96.

Lam Research Stock Performance

Shares of NASDAQ LRCX opened at $116.96 on Monday. The company has a market cap of $148.03 billion, a PE ratio of 28.12, a PEG ratio of 1.50 and a beta of 1.76. The firm's 50-day moving average price is $101.07 and its 200-day moving average price is $86.80. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $117.50. The company has a quick ratio of 1.55, a current ratio of 2.21 and a debt-to-equity ratio of 0.38.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share for the quarter, beating analysts' consensus estimates of $1.21 by $0.12. The company had revenue of $5.17 billion for the quarter, compared to the consensus estimate of $4.99 billion. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. The firm's revenue for the quarter was up 33.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.03 earnings per share. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. As a group, analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th will be given a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 0.9%. This is a positive change from Lam Research's previous quarterly dividend of $0.23. The ex-dividend date is Wednesday, September 24th. Lam Research's payout ratio is currently 25.00%.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.